The Coronavirus Risk Associations and Longitudinal Evaluation Study

What is the Purpose of this Study?

This study seeks to determine the sociodemographic, clinical, lifestyle/environmental, and molecular determinant of risks and outcomes including but not restricted to following groups of people: (1) patients with confirmed/suspected or possible SARS-CoV-2 exposure/COVID-19 infection, (2) healthcare workers caring for COVID-19 patients, (3) possible, probable, or definite community contacts of COVID-19 patients, (4) possible, probable, or definite regional contacts of COVID-19 patients, (5) anonymous web survey respondents in the community Detailed objectives are provided in the grant.


Eligibility

Not Available


Where can I participate?

  • CS Cancer at Cedars-Sinai Medical Center
  • CS Cancer at The Angeles Clinic and Research Institute



What is the full name of this clinical trial?

IIT2020-30-FIGUEIREDO-COR: The Coronavirus Risk Associations and Longitudinal Evaluation Study

Study Details
Disease Type/Condition

Multiple Myeloma, Non-Hodgkin's Lymphoma

Principal Investigator

Figueiredo, Jane

Co-Investigators

Juila Levy, Maimoona Nadri

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

STUDY00001316


How do I learn more about this study?
Email
clinicaltrials@cshs.org
Study Detail
Disease Type/Condition

Multiple Myeloma, Non-Hodgkin's Lymphoma

Principal Investigator

Figueiredo, Jane

Age Group

Adult

Phase

N/A (Cancer Control)

IRB Number

IIT2020-30-FIGUEIREDO-COR


Contact
Email
clinicaltrials@cshs.org